Category: habitual

The Future of Healthcare, and the Tech Companies Out to Improve It


This post is by The Seedcamp Team from Seedcamp


What HealthTech pioneers can learn from FinTech

In any industry, when a gap between supply and demand is prevalent and existing regulation fails to step in, the role of innovation for the public good is often taken up by startups. Nowhere is this more evident than in the healthcare space. Large delays in innovation linked to complex and widely different healthcare systems around the world, as well as outdated legacy software all provide the perfect foundation for wide-scale disruption. The sudden shifts in what we considered to be “normal” life through the COVID-19 pandemic shed light on the tremendous speed at which HealthTech startups are able to deploy lasting positive changes in our daily lives when given the right catalyst. 

Crises as a catalyst

There are certain parallels that can be drawn between the speed at which HealthTech solutions have been deployed to meet pressing needs and the FinTech boom over the last decade. We believe that the broader healthcare industry will follow FinTech’s trajectory.The 2008 financial crisis served as an inflection point; people lost trust in banking systems, which resulted in increased awareness in taking ownership over personal finances. Customers started looking for alternative, personalised and more engaging services as a consequence, coupled with the growing regulatory openings such as PSD2 on Open Banking.

For Healthtech, the COVID-19 pandemic proved to be the inflection point. As healthcare took centre stage in global discussions, individual awareness grew dramatically and an urgent need for personalised and alternative care solutions has arisen. (Read more...)

Founder Q&A with Habitual Co-Founders Napala Pratini and Ian Braithwaite


This post is by Kate McGinn from Seedcamp


When Napala Pratini and Ian Braithwaite met at Counterweight, a diabetes reversal research company, they had no idea that their coworker relationship would turn into a co-founder one. But after seeing that the life-changing diabetes reversal programmes available in research trials were not scaling quickly enough to meet market demand, they put their heads together to co-found Habitual. Habitual provides a unique combination of digital therapeutics and nutritional treatment that reverses and prevents chronic diseases like type 2 diabetes. We are thrilled to back Ian and Napala alongside MMC Ventures in their £325k pre-seed round. We backed the Habitual team because we believe in their vision of not just preventing, but also reversing, chronic disease by putting patients at the centre of the healthcare ecosystem. Recently, we had the chance to speak with Napala and Ian to learn more about Habitual’s journey to-date and the team’s vision moving forward.

Tell me a little bit more about Habitual.

Ian: Habitual is a digital diabetes prevention and reversal company, and we’re on a mission to reverse type 2 diabetes for as many patients as possible. We do it by combining two things. The first is a nutritional treatment called total diet replacement, which helps people to lose 15 kilograms safely, quickly, and reliably. This is a key number because the evidence shows that to reverse type 2 diabetes, patients need to lose about 15kg. That level of weight loss allows the pancreas to start functioning normally again—and thus reverses type 2 (Read more...)